Prenatal diagnosis of infantile GM 2 gangliosidosis type II (Sandhoff disease) by detection of N-acetylglucosaminyl-oligosaccharides in amniotic fluid with high-performance liquid chromatography.
Prenatal diagnosis of Sandhoff disease (infantile onset) at 16 weeks gestation has been made by detection and analysis of N-acetylglucosaminyl-oligosaccharides in amniotic fluid using high performance liquid chromatography. The elution profile for the branched chain oligosaccharides was identical with that obtained with neonatal and infantile Sandhoff urine. The concentration of the oligosaccharides in the fluid was 1/100th that of urine but when calculated relative to creatinine the levels were similar. No oligosaccharides were detected in normal control amniotic fluids (10 patients) at a similar gestational age. Based on the levels of the amniotic fluid oligosaccharides and the sensitivity limits of the assay, prenatal diagnosis of patients with the juvenile onset form of the disease may also be possible with this technique.
D000117:Acetylglucosamine / Q000032:analysis* / Q000652:urine; D000653:Amniotic Fluid / Q000032:analysis*; D002851:Chromatography, High Pressure Liquid; D005260:Female; D005944:Glucosamine / Q000031:analogs & derivatives*; D006801:Humans; D009844:Oligosaccharides / Q000032:analysis* / Q000652:urine; D011247:Pregnancy; D011296:Prenatal Diagnosis; D012497:Sandhoff Disease / Q000175:diagnosis*
D009844:Oligosaccharides; D005944:Glucosamine; D000117:Acetylglucosamine